Nocardia: Difference between revisions
From IDWiki
Nocardia
mNo edit summary |
No edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
===Microbiology=== |
===Microbiology=== |
||
− | *Beaded [[Stain::Gram-positive]] [[Stain::partially acid-fast]] [[Shape::bacillus]] |
+ | *Beaded [[Stain::Gram-positive]] [[Stain::partially acid-fast]] [[Shape::bacillus]] within the class [[Class::Actinobacteria]] and order [[Order::Corynebacteriales]] |
+ | *Catalase [[Catalase::positive]] and lyzozyme resistant |
||
⚫ | |||
+ | *Has a classic beaded branching cell morphology |
||
⚫ | |||
+ | *Colonies are slow to grow and have a chalky white appearance |
||
+ | *Ubiquitous environmental saprophyte found in soil and water |
||
+ | |||
+ | === Pathophysiology === |
||
+ | |||
+ | * Spores or mycelia are either inhaled into the lungs or directly inoculated in the skin and soft tissue |
||
+ | * Traumatic inoculation includes during motor vehicle collisions, mild scratches or pricks, or nosocomial with dirt entering through an open wound or central line |
||
+ | * Forms difficult-to-treat biofilms when involved in [[CLABSI|CLABSIs]] |
||
+ | |||
+ | === Risk Factors === |
||
+ | |||
+ | * More common in immunocompromised (cell-mediated immunodeficiency including [[HIV]], hematologic malignancy, and transplant patients), though can also occur in immunocompetent who have [[COPD]], [[bronchiectasis]], and [[cystic fibrosis]] |
||
+ | * Among transplant recipients, [[lung transplant]] appears to be highest risk |
||
+ | * High-dose steroids and high levels of [[calcineurin inhibitors]] appear to be specific risk factors |
||
+ | * Also diabetes and alcohol use |
||
+ | |||
+ | == Clinical Manifestations == |
||
+ | |||
+ | === Primary Cutaneous === |
||
+ | |||
+ | * Typically acquired by direct inoculation with soil |
||
+ | * [[Nocardia brasiliensis]] is the most common cause in North America |
||
+ | * May present with superficial soft tissue infection, including ulcer, abscess, cellulitis, pustules, plaques, or papules, most commonly on the arms and legs |
||
+ | * Can progress to lymphocutaneous infection with [[sporotrichoid lesions]] |
||
+ | |||
+ | === Pulmonary === |
||
+ | |||
+ | * Subacute or chronic cough, dyspnea, fever, with or without pleuritic chest pain |
||
+ | * Most common form of disease in US |
||
+ | * Colonization also possible, particularly with patients who have structural lung changes like [[cystic fibrosis]] |
||
+ | * Starts with inflammation followed by formation of granulomas and necrotic abscesses |
||
+ | * Imaging typically showed lung nodules, lobar consolidation, and pleural effusion, and may show infiltrates and necrotizing granulomas |
||
+ | ** Usually bilateral |
||
+ | ** Cavitations more common in immunocompromised patients |
||
+ | |||
+ | === Disseminated === |
||
+ | |||
+ | * Usually starts with a focal infection (skin or lung), which then disseminates hematogenously |
||
+ | * Most commonly involves skin, lungs, and CNS, but can also disseminate to kidney, joint, retina, and heart |
||
+ | * Much more common in immunosuppressed patients |
||
+ | |||
+ | === CNS Disease === |
||
+ | |||
+ | * Most common site of hematogenous dissemination |
||
+ | * Presents with typical symptoms of fever, headache, meningismus, seizure, and focal neurologic deficits |
||
+ | * Can also be asymptomatic, so immunocompromised patients should get imaging and possibly LP |
||
+ | |||
+ | === Other === |
||
+ | |||
+ | * [[Mycetoma]] |
||
+ | * [[Bacteremia]] |
||
+ | * Ocular infection, either from direct inoculation or hematogenous spread |
||
+ | * Bone and joint infection, primarily from dissemination |
||
==Management== |
==Management== |
||
+ | === Further Evaluation === |
||
+ | |||
+ | * Consider screening MRI brain in all patients with disseminated or pulmonary disease regardless of neurologic symptoms |
||
+ | * Consider CT chest in all patients |
||
+ | * Consider assessment for immunodeficiency; at the very least, HIV testing and a good history |
||
+ | |||
+ | === Antimicrobial Selection === |
||
*Mild to moderate: [[Is treated by::TMP-SMX]] |
*Mild to moderate: [[Is treated by::TMP-SMX]] |
||
**Immunocompetent: 5-10 mg/kg split tid to qid |
**Immunocompetent: 5-10 mg/kg split tid to qid |
||
Line 21: | Line 83: | ||
* Any non-cutaneous disease in immunocompromised host: at least 12 months, and possibly lifelong suppression |
* Any non-cutaneous disease in immunocompromised host: at least 12 months, and possibly lifelong suppression |
||
+ | === Monitoring === |
||
⚫ | |||
+ | |||
+ | * Serial CT scans to assess response to therapy |
||
⚫ | |||
[[Category:Gram-positive bacilli]] |
[[Category:Gram-positive bacilli]] |
Latest revision as of 18:05, 12 March 2023
Background
Microbiology
- Beaded Gram-positive partially acid-fast bacillus within the class Actinobacteria and order Corynebacteriales
- Catalase positive and lyzozyme resistant
- Has a classic beaded branching cell morphology
- Microscopic appearance similar to Actinomyces, differentiated by acid fast staining (Actinomyces is not acid fast)
- Colonies are slow to grow and have a chalky white appearance
- Ubiquitous environmental saprophyte found in soil and water
Pathophysiology
- Spores or mycelia are either inhaled into the lungs or directly inoculated in the skin and soft tissue
- Traumatic inoculation includes during motor vehicle collisions, mild scratches or pricks, or nosocomial with dirt entering through an open wound or central line
- Forms difficult-to-treat biofilms when involved in CLABSIs
Risk Factors
- More common in immunocompromised (cell-mediated immunodeficiency including HIV, hematologic malignancy, and transplant patients), though can also occur in immunocompetent who have COPD, bronchiectasis, and cystic fibrosis
- Among transplant recipients, lung transplant appears to be highest risk
- High-dose steroids and high levels of calcineurin inhibitors appear to be specific risk factors
- Also diabetes and alcohol use
Clinical Manifestations
Primary Cutaneous
- Typically acquired by direct inoculation with soil
- Nocardia brasiliensis is the most common cause in North America
- May present with superficial soft tissue infection, including ulcer, abscess, cellulitis, pustules, plaques, or papules, most commonly on the arms and legs
- Can progress to lymphocutaneous infection with sporotrichoid lesions
Pulmonary
- Subacute or chronic cough, dyspnea, fever, with or without pleuritic chest pain
- Most common form of disease in US
- Colonization also possible, particularly with patients who have structural lung changes like cystic fibrosis
- Starts with inflammation followed by formation of granulomas and necrotic abscesses
- Imaging typically showed lung nodules, lobar consolidation, and pleural effusion, and may show infiltrates and necrotizing granulomas
- Usually bilateral
- Cavitations more common in immunocompromised patients
Disseminated
- Usually starts with a focal infection (skin or lung), which then disseminates hematogenously
- Most commonly involves skin, lungs, and CNS, but can also disseminate to kidney, joint, retina, and heart
- Much more common in immunosuppressed patients
CNS Disease
- Most common site of hematogenous dissemination
- Presents with typical symptoms of fever, headache, meningismus, seizure, and focal neurologic deficits
- Can also be asymptomatic, so immunocompromised patients should get imaging and possibly LP
Other
- Mycetoma
- Bacteremia
- Ocular infection, either from direct inoculation or hematogenous spread
- Bone and joint infection, primarily from dissemination
Management
Further Evaluation
- Consider screening MRI brain in all patients with disseminated or pulmonary disease regardless of neurologic symptoms
- Consider CT chest in all patients
- Consider assessment for immunodeficiency; at the very least, HIV testing and a good history
Antimicrobial Selection
- Mild to moderate: TMP-SMX
- Immunocompetent: 5-10 mg/kg split tid to qid
- Immunocompromised: 15 mg/kg split tid to qid
- Severe: TMP-SMX plus either amikacin or imipenem
- Other antimicrobials include ceftriaxone, minocycline, and linezolid
Duration
- Isolated cutaneous infection in immunocompetent host: 3 to 6 months
- Isolated cutaneous infection in immunocompromised host: 6 to 12 months
- Serious pulmonary infection: 6 to 12 months or longer
- Any non-cutaneous disease in immunocompromised host: at least 12 months, and possibly lifelong suppression
Monitoring
- Serial CT scans to assess response to therapy
- Monitoring for antibiotic toxicity